Conference
Gemifloxacin long-term outcomes in bronchitis exacerbations (GLOBE) study - An assessment of health outcome benefits in aecb patients following 5 days' gemifloxacin (GEMI) therapy
Authors
Wilson R; Ball P; Mandell L; File T; Kirsch J; Chinn C; Henkel T
Volume
47
Pagination
pp. 44-44
Publisher
OXFORD UNIV PRESS
Publication Date
June 1, 2001
Conference proceedings
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
ISSN
0305-7453